Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD TherapyArticle Published on 2021-05-042023-08-30 Journal: Frontiers in Immunology [Category] E형 간염, [키워드] homing IBD retention T cell therapy Trafficking [DOI] 10.3389/fimmu.2021.656452 PMC 바로가기
Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBDSARS-CoV-2 감염에 대한 항체 반응은 인플릭시맙 치료를 받은 IBD 환자에서 약화됩니다Comment Published on 2021-05-012022-09-12 Journal: Nature reviews. Gastroenterology & hepatology [Category] Fulltext, SARS, 진단, [키워드] Antibody Response IBD Patient SARS-COV-2 infection [DOI] 10.1038/s41575-021-00445-1 PMC 바로가기 [Article Type] Comment
Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemicCOVID-19 전염병 동안 소아 염증성 장 질환 환자의 현장 진료 대변 칼프로텍틴 검사Article Published on 2021-05-012022-09-11 Journal: BMJ open gastroenterology [Category] 바이오마커, [키워드] alternative automatically benefit bowel calprotectin change Clinical management COVID-19 pandemic Crohn's disease decision Disruption had no help home hospital IBD Inflammatory Inflammatory bowel disease Laboratory test Laboratory testing Laboratory tests less management modify offer Patient patients portal produced questionnaire reduce required Stool stool markers ulcerative colitis user [DOI] 10.1136/bmjgast-2021-000631 PMC 바로가기 [Article Type] Article
The impact of SARS-CoV-2 variants on IBD managementSARS-CoV-2 변이가 IBD 관리에 미치는 영향Article Published on 2021-05-012022-09-11 Journal: The Lancet. Gastroenterology & Hepatology [Category] Fulltext, SARS, 변종, [키워드] IBD management SARS-CoV-2 variant [DOI] 10.1016/S2468-1253(21)00075-3 PMC 바로가기 [Article Type] Article
Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment optionsCase Series Published on 2021-04-292022-10-28 Journal: Therapeutic Advances in Gastroenterology [Category] COVID-19, [키워드] acute respiratory syndrome acute ulcerative colitis Alpha Asymptomatic biopsies Case series clinical clinical observations coronavirus disease Coronavirus-2 COVID-19 COVID-19 patient diagnosed Diagnosis drug Evidence Future Histopathology IBD immunomodulatory drug immunomodulatory drugs Inflammatory bowel disease inhibitors International knowledge nasopharynx National Necrosis pandemic parameters Patient patients patients with COVID-19 question Research RT-PCR SARS-CoV-2 Standard steroid Steroids stools therapeutic Therapies therapy treated Treatment treatment regimen ulcerative colitis use of steroids [DOI] 10.1177/17562848211012595 PMC 바로가기 [Article Type] Case Series
Children With Inflammatory Bowel Disease in the COVID-19 Main Endemic Focus: The Lombardy ExperiencePediatrics Published on 2021-04-212022-10-31 Journal: Frontiers in Pediatrics [Category] COVID-19, [키워드] acute respiratory syndrome children Colitis coronavirus COVID-19 cross-sectional survey diagnose diagnosed experience Hospitalization IBD immunosuppressed patients Immunosuppression Infection Inflammatory bowel disease Last lockdown lombardy medical record Mild symptom mild symptoms Modification New no significant difference no statistical difference occurred pandemic Patient Prevalence question raised returned SARS-CoV-2 SARS-COV-2 infection Seven Standard Symptom Treatment [DOI] 10.3389/fped.2021.607285 PMC 바로가기 [Article Type] Pediatrics
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in ColitisOriginal Article Published on 2021-04-012024-09-04 Journal: Journal of Crohn's and Colitis [Category] 대상포진, [키워드] experimental colitis IBD Janus kinase inhibitor Tyrosine kinase 2 inhibitor [DOI] 10.1093/ecco-jcc/jjaa199 PMC 바로가기 [Article Type] Original Article
Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemicOriginal Article Published on 2021-03-292022-10-29 Journal: JGH Open: An Open Access Journal of Gastroenterology and Hepatology [Category] COVID-19, [키워드] association complementary coronavirus disease Corticosteroid COVID‐19 COVID‐19 Critical Disease activity dose dose reduction driving female gastroenterology IBD immunology Immunosuppressive medication infection risk Inflammatory bowel disease measure median age medication medication adherence medications Medicine mental health microbiology and inflammatory bowel diseases outcomes pandemic Patient patients Prevalence Prevent reduced reported Result risk therapy understanding widespread [DOI] 10.1002/jgh3.12537 PMC 바로가기 [Article Type] Original Article
Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal diseaseReview Published on 2021-03-242022-10-29 Journal: Italian Journal of Pediatrics [Category] COVID-19, SARS, [키워드] 2019 coronavirus disease ACE2 acute respiratory syndrome adverse outcomes approach benefit Care changed children chronic diarrhea chronic disease chronic liver disease clinical implication coronavirus COVID-19 Diagnosis digestive Digestive endoscopy disease Diseases disorder Follow-up visit functional Functional gastrointestinal disorders gastrointestinal disease gastrointestinal symptoms high risk IBD Immunosuppression infected children Infection Inflammatory bowel disease Liver disease management pandemic era parent Patient pediatric pediatrics Personal protective equipment protocol Psychological regimen risk risk factor SARS-CoV-2 SARS-CoV-2 vaccination social distancing therapeutic Treatment Viral transmission [DOI] 10.1186/s13052-021-01020-9 PMC 바로가기 [Article Type] Review
Management of Crohn’s disease in an immunosuppressed COVID-19-positive patient: safety-driven prioritisation of nutritional therapy as a bridge to restarting immunosuppression면역 억제된 COVID-19 양성 환자의 크론병 관리: 면역 억제를 다시 시작하기 위한 다리로서 영양 요법의 안전 중심 우선 순위 지정Case Reports Published on 2021-03-222022-09-12 Journal: BMJ case reports [Category] SARS, 진단, [키워드] Antibody Response bowel complex corticosteroid therapy COVID-19 infection Crohn's disease disease highlight IBD Immunosuppressed Immunosuppression Inflammatory Inflammatory bowel disease management outcome Patient presenting risk factor SARS-CoV-2 IgG SARS-CoV-2 PCR testing therapy [DOI] 10.1136/bcr-2020-239404 PMC 바로가기 [Article Type] Case Reports